

Wara Samar
31st January 2025
Mulder Raises €597K to Enhance MedTech Compliance with Blockchain
Mulder, a female-led and minority-owned MedTech SaaS startup based in London, has raised €597,000 in a rolling pre-seed funding round led by SFC Capital. This investment, bolstered by support from Innovate UK through a SMART Grant, will propel Mulder’s development of a blockchain-powered platform aimed at enhancing transparency and compliance in the medical device supply chain.
The funding will enable Mulder to advance its mission of addressing regulatory compliance challenges that medical device manufacturers face. The company’s blockchain-based solution is designed to streamline regulatory adherence, improve recall management, and ensure comprehensive traceability across the supply chain. By integrating blockchain technology, Mulder aims to provide manufacturers with a reliable tool to meet evolving industry regulations and enhance operational efficiency.
Strong Leadership and Market Potential
Founded in 2023 by Michelle Kuei, Sriya Deokar, and Prathyusha Kadivella, Mulder’s leadership team brings a wealth of expertise in healthcare innovation, regulatory affairs, and technology development. Their collective experience positions the company as a strong player in the MedTech sector, particularly as regulatory frameworks such as the EU Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) continue to impose stricter compliance requirements.

As the medical device industry adapts to advancements in AI, IoT, and data-driven supply chain management, the need for secure and transparent solutions has become increasingly evident. Mulder’s blockchain-based platform aligns with these technological shifts, offering manufacturers a comprehensive approach to navigating regulatory complexities while ensuring traceability and security.
Expansion and Future Prospects
The company has identified a substantial market opportunity, with the global medical device sector projected to reach a total addressable market of £40 billion in 2024. Initially, Mulder is targeting the UK’s SME medical device manufacturers, using this market as a foundation for international expansion. Future growth plans include entering key global markets such as the US, EU, Japan, India, and Taiwan, where compliance and traceability solutions are in high demand.
In preparation for its commercial launch, Mulder is engaging with industry partners to participate in pilot programs, offering early access to its platform. These pilot initiatives will provide valuable insights and help refine the technology for broader deployment.
Looking ahead, the company is set to open the second tranche of its pre-seed round in early 2025. This next phase of funding is expected to support further development, industry collaborations, and market expansion. With strategic backing from investors and regulatory bodies, Mulder is positioned to establish itself as a key innovator in MedTech compliance solutions, paving the way for a more transparent and efficient medical device supply chain.
Join the Conversation at MedTech World Dubai
MedTech World Dubai takes place on February 23-24, 2025, bringing together industry leaders, innovators, and investors to explore the latest advancements in medical technology. Don’t miss the opportunity to engage in discussions on regulatory trends, digital health solutions, and emerging MedTech innovations. Register now to be part of this global gathering!
